Publications

AZEPTIC Trial -
Journal of Critical Care Medicine 2011
A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multi-center, controlled, randomized trial

Journal of Antimicrobial Chemotherapy 2009
Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions

Journal of Infection 2010
In vitro and in vivo evaluation of efficacy of citrate/methylene blue/parabens/IPA solution as a skin disinfectant

Nephrology Dialysis Transplantation 2009
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens)

New Ag Products

ZuraLac™ is specifically formulated to sanitize and protect teats from mastitis causing organisms, and protect teat skin tissue from harsh environmental conditions.

Learn More

Contact

Zurex Pharma's corporate office is located in the Middleton Industrial Park. Specific comments or questions may be submitted online through our contact page.

Contact Zurex

ZuraPrep™

Presurgical skin preparation for the prevention of surgical site infections.

ZurAsept™

Prevention of intra-luminal catheter-related bloodstream infections in central line catheters.

ZuraGard™

Prevention of extra-luminal or “exit site” wound catheter-related bloodstream infections.

Publications

Read more about the Zurex product lines from other publications and scientific journals.

Visit Publications Page

Zurex Product Line

Our goal is to provide safe and effective anti-microbial products designed to reduce the risks associated with healthcare acquired infections with a focus on surgical site wounds and catheter-related bloodstream infections (CRBSI).